Hypera SA - Company Profile

Powered by

All the data and insights you need on Hypera SA in one report.

$395 $295
Buy Report View Sample
  • Save hours of research time and resources with
    our up-to-date Hypera SA Strategy Report

  • Understand Hypera SA position in the market,
    performance and strategic initiatives.

  • Gain competitive edge and increase your
    chances of success

Back to companies

Hypera SA: Overview

Select Item

Hypera SA (Hypera Pharma) develops, manufactures and markets pharmaceutical and healthcare products. The company operates through prescription products, consumer health, and similar and generic businesses. Its products include sweeteners, anti-flu medications, painkillers, vitamins and supplements, solutions, and tablets for heartburn and poor digestion. Hypera Pharma also offers medicines for dermatology, pediatrics, gastroenterology, women's health, cardiometabolic, musculoskeletal, rheumatology, respiratory, central nervous system, and ophthalmology indications. The company markets its products online and through a network of distributors and wholesale stores in Brazil. It operates distribution centers in Annapolis and Goiania, Brazil. Hypera Pharma is headquartered in Sao Paulo, Brazil.

 Gain a 360-degree view of Hypera SA and make more informed decisions for your business Gain a 360-degree view of Hypera SA and make more informed decisions for your business Find out more
Headquarters Brazil
Address Rua Nova Cidade, 404, Vila Olimpia, Sao Paulo, 04.547-070
Website www.hypera.com.br
Telephone 55 11 36274206
No of Employees 9,000
Industry Pharmaceuticals and Healthcare
Ticker Symbol & Exchange HYPE3 (SAO)
Revenue (2022) $1.6B 4.9% (2022 vs 2021)
EPS XYZ
Net Income (2022) XYZ -2.9% (2022 vs 2021)
Market Cap* $3.4B
Net Profit Margin (2022) XYZ -7.4% (2022 vs 2021)
* As of and is in US$
View Hypera SA financials
Gain access to our premium signals and make informed decisions for your business Gain access to our premium signals and make informed decisions for your business Find out more

Hypera SA premium industry data and analytics

270+

Marketed Drugs

Understand Hypera SA’s commercialized product portfolio to stay one step ahead of the market.

20+

Clinical Trials

Determine Hypera SA go-to-market proposition and gain insight into the company’s clinical operations, recruitment, and trial strategy.

8

Catalyst Calendar

Proactively evaluate Hypera SA’s catalyst impacts to stay ahead of the competition & improve corporate planning. Bolster business development with timely opportunities.

3

Pipeline Drugs

Identify which of Hypera SA’s products will be commercialized, helping you to better contend with shifting product portfolios, and allowing you to stay one step ahead of the market.

1

IT Services Contracts

Improve competitive bidding with insights into all publicly disclosed IT services contracts for Hypera SA (including IT outsourcing, business process outsourcing, systems integration & consulting and more).

1

ICT Spend & Tech Priorities

IT Client Prospector provides intelligence on Hypera SA’s likely spend across technology areas enabling you to understand the digital strategy.

Products and Services

Products Brands
Sweeteners Predsim
Anti-flu Medications Celestamine
Prescription Maxtest
XYZ XYZ
XYZ XYZ
XYZ XYZ
Understand Hypera SA portfolio and identify potential areas for collaboration Understand Hypera SA portfolio and identify potential areas for collaboration Find out more
Image for loader

Competitor Comparison

Key Parameters Hypera SA Johnson & Johnson Bristol-Myers Squibb Co GSK plc Amgen Inc
Headquarters Brazil United States of America United States of America United Kingdom United States of America
City Sao Paulo New Brunswick Princeton Brentford Thousand Oaks
State/Province - New Jersey New Jersey England California
No. of Employees 9,000 131,900 34,100 70,212 26,700
Entity Type Public Public Public Public Public
Benchmark the company against the market with exclusive information on key competitors Benchmark the company against the market with exclusive information on key competitors Find out more
Chart Financial activity with access to more key stats Chart Financial activity with access to more key stats Find out more
Executives
Name Position Board Since Age
Alvaro Stainfeld Link Chairman Executive Board 2021 53
Breno Toledo Pires de Oliveira Director; Chief Executive Officer Executive Board 2021 48
Ramon Sanches Frutuoso Silva Chief Financial Officer Senior Management 2022 36
Luiz Eduardo Sales Clavis Vice President - Commercial and Marketing Senior Management 2018 52
David Coury Neto Director Non Executive Board 2021 68
Non Dignissim Eros Proin vel Convallis 2024 XY
Non Dignissim Eros Proin vel Convallis 2024 XY
Non Dignissim Eros Proin vel Convallis 2024 XY
Gain insight into Hypera SA key executives to enhance your sales strategy Gain insight into Hypera SA key executives to enhance your sales strategy Find out more
Still looking?

Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.

Explorer

Access more premium companies when you subscribe to Explorer

Get in touch about GlobalData Company reports

Contact the team or request a demo to find out how our data can drive your business forward